ArticleBlood advances2026

Peritransplant molecular MRD monitoring by targeted NGS in patients with FLT3-ITD-mutated acute myeloid leukemia.

Xiaoxia Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.